BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19048245)

  • 1. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
    Xin HW; Xiong H; Wu XC; Li Q; Xiong L; Yu AR
    Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
    Vannaprasaht S; Angsuthum S; Avihingsanon Y; Sirivongs D; Pongskul C; Makarawate P; Praditpornsilpa K; Tassaneeyakul W; Tassaneeyakul W
    Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
    Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
    Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.
    Xiong H; Xin HW; Wu XC; Li Q; Xiong L; Yu AR
    Fundam Clin Pharmacol; 2010 Jun; 24(3):393-400. PubMed ID: 19682085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
    Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
    Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Lener A; Drozdzik M
    Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
    Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
    Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK; Zhao J; Zhang LR
    J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine.
    Jun JB; Cho DY; Kang C; Bae SC
    Clin Exp Rheumatol; 2005; 23(6):873-6. PubMed ID: 16396707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
    Fabre MA; Jones DC; Bunce M; Morris PJ; Friend PJ; Welsh KI; Marshall SE
    Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
    Zhu Q; Cao Q
    Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
    Breen DP; Marinaki AM; Arenas M; Hayes PC
    Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.
    Coucoutsi C; Emmanouil G; Goulielmos G; Sfakianaki O; Koutroubakis IE; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
    Takatsu N; Matsui T; Murakami Y; Ishihara H; Hisabe T; Nagahama T; Maki S; Beppu T; Takaki Y; Hirai F; Yao K
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
    Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
    J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation.
    Liang JJ; Geske JR; Boilson BA; Frantz RP; Edwards BS; Kushwaha SS; Kremers WK; Weinshilboum RM; Pereira NL
    Pharmacogenet Genomics; 2013 Dec; 23(12):658-65. PubMed ID: 24121523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.